Noriaki Nagai Selected Research

Sericins (Sericin)

5/2019	Therapeutic Potential of a Combination of Magnesium Hydroxide Nanoparticles and Sericin for Epithelial Corneal Wound Healing.
12/2013	Therapeutic effects of sericin on diabetic keratopathy in Otsuka Long-Evans Tokushima Fatty rats.
1/2013	Decrease in corneal damage due to benzalkonium chloride by the addition of sericin into timolol maleate eye drops.
9/2009	Enhancing effects of sericin on corneal wound healing in Otsuka Long-Evans Tokushima fatty rats as a model of human type 2 diabetes.
5/2009	Enhancing effects of sericin on corneal wound healing in rat debrided corneal epithelium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Noriaki Nagai Research Topics

Disease

41	Cataract (Cataracts) 12/2023 - 01/2006
12	Wounds and Injuries (Trauma) 11/2023 - 05/2009
12	Rheumatoid Arthritis 11/2023 - 01/2009
12	Arthritis (Polyarthritis) 04/2020 - 10/2007
11	Inflammation (Inflammations) 05/2023 - 10/2007
11	Diabetes Mellitus 03/2021 - 01/2009
10	Corneal Injuries 01/2021 - 09/2009
10	Glaucoma 01/2018 - 01/2010
9	Type 2 Diabetes Mellitus (MODY) 05/2019 - 01/2009
9	Body Weight (Weight, Body) 02/2019 - 01/2009
6	Uveitis 08/2023 - 10/2010
4	Presbyopia 12/2023 - 03/2021
4	Hyperglycemia 03/2021 - 01/2013
4	Edema (Dropsy) 01/2015 - 10/2007
3	Ischemic Stroke 04/2021 - 12/2015
3	Brain Ischemia (Cerebral Ischemia) 04/2021 - 12/2015
2	Sclerosis 12/2023 - 12/2021
2	Hemorrhage 11/2023 - 10/2019
2	Stomatitis 01/2023 - 06/2020
2	Neoplasms (Cancer) 12/2021 - 01/2020
2	Dry Eye Syndromes (Dry Eye Syndrome) 01/2021 - 02/2020
2	Obesity 02/2019 - 01/2013
2	Cerebral Infarction 04/2018 - 01/2018
2	Osteoporosis 01/2018 - 01/2014
2	Hypercalcemia (Milk Alkali Syndrome) 01/2016 - 01/2015
2	Ocular Hypertension (Glaucoma, Suspect) 01/2013 - 01/2010

Drug/Important Bio-Agent (IBA)

22	Ophthalmic Solutions (Eye Drops)IBA 12/2023 - 08/2007
11	Therapeutic UsesIBA 11/2023 - 01/2014
11	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2021 - 11/2007
11	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 01/2009
10	Disulfiram (Antabuse)FDA Link 01/2015 - 12/2007
9	Indomethacin (Indometacin)FDA LinkGeneric 11/2023 - 01/2009
9	Proteins (Proteins, Gene)FDA Link 05/2023 - 10/2006
9	MagnesiumIBA 01/2017 - 01/2006
8	SuspensionsIBA 02/2022 - 10/2007
8	Messenger RNA (mRNA)IBA 03/2021 - 10/2006
8	Adenosine Triphosphatases (ATPase)IBA 07/2020 - 12/2007
7	Adenosine Triphosphate (ATP)IBA 01/2023 - 01/2007
7	SolutionsIBA 03/2015 - 08/2007
6	EndotoxinsIBA 08/2023 - 10/2010
6	Interleukin-18 (Interleukin 18)IBA 01/2016 - 11/2007
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2023 - 01/2009
5	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 06/2019 - 12/2007
5	Sericins (Sericin)IBA 05/2019 - 05/2009
5	Timolol (Blocadren)FDA LinkGeneric 01/2018 - 01/2011
4	LipopolysaccharidesIBA 08/2023 - 09/2021
4	hesperetinIBA 01/2023 - 07/2018
4	Ointments (Pastes)IBA 01/2023 - 01/2014
4	CalpainIBA 07/2022 - 02/2020
4	Retinaldehyde (Retinal)IBA 02/2022 - 01/2013
4	Cilostazol (Pletal)FDA LinkGeneric 04/2021 - 12/2015
4	HCEIBA 01/2021 - 01/2011
4	rebamipideIBA 06/2020 - 10/2016
4	Amyloid (Amyloid Fibrils)IBA 01/2017 - 01/2014
4	CalciumIBA 01/2016 - 01/2007
4	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 01/2015 - 01/2010
4	Triglycerides (Triacylglycerol)IBA 01/2013 - 01/2009
3	AcidsIBA 08/2023 - 04/2020
3	CytokinesIBA 05/2023 - 01/2013
3	Sodium SeleniteIBA 07/2022 - 07/2018
3	EnzymesIBA 03/2021 - 01/2015
3	Selenious Acid (Selenite)IBA 03/2021 - 11/2017
3	Nitric Oxide Synthase (NO Synthase)IBA 10/2019 - 05/2008
3	pimagedine (aminoguanidine)IBA 12/2018 - 12/2007
3	Streptozocin (Streptozotocin)FDA Link 12/2017 - 09/2017
3	Insulin (Novolin)FDA Link 09/2017 - 01/2009
3	Methylcellulose (BFL)IBA 12/2015 - 01/2012
3	Hypromellose DerivativesIBA 01/2015 - 01/2010
3	Drinking WaterIBA 01/2014 - 06/2006
3	CholesterolIBA 01/2013 - 01/2009
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2011 - 10/2006
2	Aquaporins (Water Channels)IBA 12/2023 - 12/2021
2	HydrogelsIBA 01/2023 - 06/2020
2	Crystallins (Crystallin)IBA 01/2023 - 11/2017
2	nilvadipine (Escor)IBA 07/2022 - 11/2021
2	TabletsIBA 02/2022 - 01/2018
2	glucosyl hesperidinIBA 12/2021 - 03/2021
2	Blood Glucose (Blood Sugar)IBA 03/2021 - 01/2009
2	LanosterolIBA 07/2020 - 02/2020
2	tranilastIBA 04/2020 - 01/2014
2	Anti-Allergic Agents (Antiallergic Agents)IBA 04/2020 - 01/2014
2	tyramine-deoxysorbitolIBA 04/2020 - 10/2019
2	OligosaccharidesIBA 01/2020 - 10/2019
2	Magnesium Hydroxide (Brucite)FDA Link 05/2019 - 12/2017
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 02/2019 - 07/2018
2	Glutathione (Reduced Glutathione)IBA 02/2019 - 07/2018
2	Coffee FDA Link 02/2019 - 11/2017
2	AntioxidantsIBA 11/2017 - 01/2009
2	InterleukinsIBA 01/2016 - 01/2015
2	Sweetening Agents (Sweeteners)IBA 01/2015 - 01/2013
2	Antiglaucoma AgentsIBA 01/2015 - 01/2013
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2014 - 01/2011
2	InterferonsIBA 01/2013 - 06/2011
2	Latanoprost (Xalatan)FDA Link 01/2011 - 01/2010
2	Travoprost (Travatan)FDA Link 01/2011 - 01/2010
2	2-Hydroxypropyl-beta-cyclodextrinIBA 01/2010 - 08/2007
2	Lipid PeroxidesIBA 05/2008 - 05/2008

Therapy/Procedure

23	Therapeutics 01/2023 - 10/2007
16	Lenses 11/2021 - 06/2006
9	Oral Administration 11/2023 - 10/2007